InsiderTrades

Form 4 for GMED GLOBUS MEDICAL INC

Accepted 2024-09-17 00:00:00 ET · period of report 2024-09-13 · accession 0000950170-24-107316 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-09-17 2024-09-13 GMED Davidar David D Dir M - OptEx $25.52 +25.0K 591.3K +4% +$638.0K
D 2024-09-17 2024-09-13 GMED Davidar David D Dir S - Sale+OE $70.46 -25.0K 566.3K -4% -$1.76M
D 2024-09-17 2024-09-13 GMED Davidar David D Dir M - OptEx $0.00 -25.0K 25.0K -50% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2024-09-13 M A 25,000 $25.52 591,275 D — —
2 Common Class A Common Stock 2024-09-13 S D 25,000 $70.46 566,275 D — — (F1) The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at a price range of $70.20 - $70.80, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares at each separate price within the range set forth in footnote (1) of this Form 4.
3 Derivative Stock Option (Right to Buy Class A Common Stock) 2024-09-13 M D 25,000 $0.00 25,000 D $25.52 · — to 2026-01-25 25,000 Class A Common Stock (F3) These options were granted on January 25, 2016 and are fully vested.